Free Virtual Consultations. Corona Virus Related Cases Click Here.

1 Killed in Crash at Forest Avenue and Springfield Drive

4 Vehicles Involved in Fatal Chico Accident

Fatal Accident 2

Chico, CA (February 19, 2020) – One person was killed in a multi-vehicle crash in Chico. The fatal accident occurred on February 19 at Forest Avenue and Springfield Drive.

A Nissan was going north in the southbound lanes when it collided head-on with a motorcycle. The Nissan then hit two other vehicles. One person was killed in the crash. The others suffered minor injuries. The female driver of the Nissan remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.



November 27, 2019

1 Killed in Crash on 15 Freeway Near Calico Road

Man Dies in Fatal Rear-End Accident in Yermo...

November 29, 2019

1 Killed in Head-on Crash on Mt. Israel Road

Speed, Wet Roads Contribute to Fatal Escondido Accident...

February 10, 2020

Man Killed in Multi-Vehicle Crash on Highway 4 Near Bailey Road

Tony Moss Arrested for DUI in Fatal Pittsburg Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.